# Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes

> **NCT00704223** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 619 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** biphasic insulin aspart

## Key facts

- **NCT ID:** NCT00704223
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 619 (ACTUAL)
- **Last updated:** 2014-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704223, "Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00704223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*